Rise in Psychotropic Drug Prescribing in Children and Adolescents During 1992-2001: a Population-based Study in the UK

Overview

Journal Eur J Epidemiol

Specialty Public Health

Date 2009 Mar 7

PMID 19266290

Citations 19

Authors

Yingfen Hsia

Karyn Maclennan

Affiliations

Soon will be listed here.

Abstract

Background: The trend towards increased psychotropic drug prescribing in children and adolescents is well recognised in North America and continental Europe. However, it is unclear to what extent these studies are applicable to clinical practice in the United Kingdom (UK). This study was conducted to estimate the prevalence of psychotropic drug prescribing in children and adolescents aged <19 years in general practice in the UK from January 1992 to December 2001.

Methods: Data were obtained from the General Practice Research Database (GPRD). Annual age- and sex-specific prevalence of psychotropic drug prescribing was calculated.

Results: A total of 143,079 prescriptions were issued to 34,398 study subjects. Stimulant prescriptions rose significantly from 0.03 per 1,000 (95% confidence interval 0.02-0.04) in 1992 to 2.9 per 1,000 (2.52-3.32) in 2001; a 96-fold increase. Methylphenidate accounted for the majority of stimulant prescriptions; 2.4% (349/14,370) of stimulant prescriptions were prescribed to children aged <6 years. Increased prescribing was also noted for antidepressants (1.6-fold), hypnotics/anxiolytics (1.3-fold), antipsychotics (1.3-fold) and anticonvulsants (1.3-fold), whilst the prevalence of clonidine and lithium prescribing remained fairly stable throughout the study period. The use of antidepressant, hypnotic/anxiolytic and anticonvulsant increased with increasing age. A high proportion of boys received stimulants, whereas antidepressants and hypnotics/anxiolytics were more likely prescribed to girls.

Conclusion: There is an increased trend of psychotropic drug use in children and adolescents in the UK practice. Since most psychotropic drugs are not licensed for use in children at this time, research is needed to investigate the efficacy and long-term safety in this population.

Citing Articles

Psychotropic medication use among adolescents participating in three randomized trials of DBT.

Mehlum L, Asarnow J, Neupane S, Santamarina-Perez P, Prime-Tous M, Carlson G Borderline Personal Disord Emot Dysregul. 2024; 11(1):5.

PMID: 38388455 PMC: 10885477. DOI: 10.1186/s40479-024-00249-0.

Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018.

Lee S, Cheong H, Oh I, Hong M Int J Environ Res Public Health. 2021; 18(21).

PMID: 34769839 PMC: 8582649. DOI: 10.3390/ijerph182111322.

Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study.

Gomez-Lumbreras A, Garcia Sangenis A, Prat Vallverdu O, Gatell Carbo A, Vedia Urgell C, Gisbert Gustemps L Psychopharmacology (Berl). 2021; 238(7):1805-1815.

PMID: 33694030 DOI: 10.1007/s00213-021-05809-8.

A computational method to quantitatively measure pediatric drug safety using electronic medical records.

Yu G, Zeng X, Ni S, Jia Z, Chen W, Lu X BMC Med Res Methodol. 2020; 20(1):9.

PMID: 31937265 PMC: 6961323. DOI: 10.1186/s12874-020-0902-x.

Glucose and Prolactin Monitoring in Children and Adolescents Initiating Antipsychotic Therapy.

Okumura Y, Usami M, Okada T, Saito T, Negoro H, Tsujii N J Child Adolesc Psychopharmacol. 2018; 28(7):454-462.

PMID: 29889543 PMC: 6154762. DOI: 10.1089/cap.2018.0013.

References

Zito J, Safer D, dosReis S, Gardner J, Magder L, Soeken K . Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003; 157(1):17-25. DOI: 10.1001/archpedi.157.1.17. View

Bramble D . Annotation: The use of psychotropic medications in children: a British view. J Child Psychol Psychiatry. 2003; 44(2):169-79. DOI: 10.1111/1469-7610.00111. View

Jensen P, Bhatara V, Vitiello B, Hoagwood K, Feil M, Burke L . Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry. 1999; 38(5):557-65. DOI: 10.1097/00004583-199905000-00017. View

Pappadopulos E, Guelzow B, Wong C, Ortega M, Jensen P . A review of the growing evidence base for pediatric psychopharmacology. Child Adolesc Psychiatr Clin N Am. 2004; 13(4):817-55, vi. DOI: 10.1016/j.chc.2004.04.007. View

Vitiello B . Psychopharmacology for young children: clinical needs and research opportunities. Pediatrics. 2001; 108(4):983-9. DOI: 10.1542/peds.108.4.983. View

Zito J, Safer D, dosReis S, GARDNER J, Boles M, Lynch F . Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000; 283(8):1025-30. DOI: 10.1001/jama.283.8.1025. View

Hollowell J . The General Practice Research Database: quality of morbidity data. Popul Trends. 1997; (87):36-40. View

Cox E, Motheral B, Henderson R, Mager D . Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics. 2003; 111(2):237-43. DOI: 10.1542/peds.111.2.237. View

Garcia Rodriguez L, Perez Gutthann S . Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998; 45(5):419-25. PMC: 1873548. DOI: 10.1046/j.1365-2125.1998.00701.x. View

10.

Wood L, Coulson R . Revitalizing the General Practice Research Database: plans, challenges, and opportunities. Pharmacoepidemiol Drug Saf. 2002; 10(5):379-83. DOI: 10.1002/pds.608. View

11.

Kollins S, Greenhill L, Swanson J, Wigal S, Abikoff H, McCracken J . Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry. 2006; 45(11):1275-1283. DOI: 10.1097/01.chi.0000235074.86919.dc. View

12.

Murray M, de Vries C, Wong I . A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child. 2004; 89(12):1098-102. PMC: 1719765. DOI: 10.1136/adc.2004.064956. View

13.

Thapar A, Thapar A . Attention-deficit hyperactivity disorder. Br J Gen Pract. 2003; 53(488):225-30. PMC: 1314550. View

14.

Steinhausen H, Erdin A . A comparison of ICD-9 and ICD-10 diagnoses of child and adolescent psychiatric disorders. J Child Psychol Psychiatry. 1991; 32(6):909-20. DOI: 10.1111/j.1469-7610.1991.tb01918.x. View

15.

Wong I, Murray M, Camilleri-Novak D, Stephens P . Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child. 2004; 89(12):1131-2. PMC: 1719746. DOI: 10.1136/adc.2004.050468. View

16.

Rappley M, Mullan P, Alvarez F, Eneli I, Wang J, Gardiner J . Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Arch Pediatr Adolesc Med. 1999; 153(10):1039-45. DOI: 10.1001/archpedi.153.10.1039. View

17.

Walley T, Mantgani A . The UK General Practice Research Database. Lancet. 1999; 350(9084):1097-9. DOI: 10.1016/S0140-6736(97)04248-7. View

18.

. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999; 56(12):1073-86. DOI: 10.1001/archpsyc.56.12.1073. View

19.

Schirm E, Tobi H, Zito J, de Jong-van den Berg L . Psychotropic medication in children: a study from the Netherlands. Pediatrics. 2001; 108(2):E25. DOI: 10.1542/peds.108.2.e25. View

20.

Hugtenburg J, Heerdink E, Egberts A . Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol. 2004; 60(5):377-9. DOI: 10.1007/s00228-004-0765-9. View